• 1. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 2. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 3. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 4. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 5. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acid esters
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acid esters

Ethyl 3-(aminomethyl)benzoate hydrochloride (CAS No. 91843-34-4): A Comprehensive Overview

Ethyl 3-(aminomethyl)benzoate hydrochloride, with the chemical formula C₁₀H₁₄N₂O₂·HCl, is a compound of significant interest in the field of pharmaceutical research and development. This compound, identified by its CAS number 91843-34-4, has garnered attention due to its potential applications in various biochemical pathways and its role as an intermediate in the synthesis of more complex molecules. The hydrochloride salt form enhances its solubility and stability, making it a valuable asset in laboratory settings and industrial processes.

The< strong>Ethyl 3-(aminomethyl)benzoate hydrochloride molecule possesses a benzoate core substituted with an aminomethyl group, which introduces a versatile amine functionality. This structural feature allows for further chemical modifications, making it a useful building block in medicinal chemistry. The hydrochloride form ensures that the compound remains in an ionized state, which can be advantageous for certain biological applications where ionization state plays a critical role in absorption and distribution.

In recent years, there has been growing interest in the pharmacological properties of benzoate derivatives. Studies have shown that compounds containing the benzoate moiety can exhibit various biological activities, including anti-inflammatory, analgesic, and neuroprotective effects. The presence of the aminomethyl group in Ethyl 3-(aminomethyl)benzoate hydrochloride adds an additional layer of complexity, potentially influencing its interaction with biological targets. This compound has been explored as a precursor in the synthesis of more complex pharmacophores designed to modulate specific signaling pathways.

One of the most compelling aspects of Ethyl 3-(aminomethyl)benzoate hydrochloride is its potential role in drug discovery. The benzoate core is a well-known scaffold in medicinal chemistry, with numerous examples of drugs approved for various therapeutic uses. By modifying this core structure, researchers can fine-tune the pharmacological properties of the compound. The aminomethyl group provides a site for further functionalization, allowing for the creation of derivatives with enhanced binding affinity or selectivity.

Recent studies have highlighted the importance of amine-containing compounds in therapeutic applications. Amines are key components in many bioactive molecules and often serve as critical recognition elements in protein-protein interactions. Ethyl 3-(aminomethyl)benzoate hydrochloride, with its integrated amine functionality, could be a valuable tool for developing new drugs targeting these interactions. For instance, it has been investigated as a potential ligand for enzymes involved in metabolic disorders and as a component in formulations designed to enhance drug delivery systems.

The hydrochloride salt form of Ethyl 3-(aminomethyl)benzoate offers several practical advantages. Enhanced solubility compared to the free base form makes it more suitable for formulation into pharmaceutical products. Additionally, the stability provided by the hydrochloride salt ensures that the compound remains viable for extended periods under various storage conditions. These properties make it an attractive candidate for both academic research and industrial applications.

In conclusion, Ethyl 3-(aminomethyl)benzoate hydrochloride (CAS No. 91843-34-4) is a multifaceted compound with significant potential in pharmaceutical research. Its unique structural features, including the benzoate core and aminomethyl group, make it a versatile intermediate for synthesizing more complex molecules. The hydrochloride salt form enhances its utility by improving solubility and stability. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in drug development and biochemical studies.

• 93071-65-9(Methyl 3-(aminomethyl)benzoate)
• 6232-11-7(Methyl 4-(aminomethyl)benzoate hydrochloride)
• 17841-68-8(Methyl 3-(aminomethyl)benzoate Hydrochloride)
• 126926-41-8(Benzamide,3-[(acetyloxy)methyl]-)
• 650602-26-9(Benzamide, 4-[(acetyloxy)methyl]-)
• 18469-52-8(Methyl 4-(aminomethyl)benzoate)
• 366-84-7(Ethyl 4-(aminomethyl)benzoate)
• 6232-12-8(Ethyl 4-(aminomethyl)benzoate hydrochloride)
• 78950-33-1(Benzoic acid,3-(aminocarbonyl)-, ethyl ester)
• 89760-85-0(Benzoic acid, 3-(aminomethyl)-, (2,4,6-trimethylphenyl)methyl ester)